The treatment has been shown to be active against third generation cephalosporin-resistant Enterobacterales species. Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and probenecid, ...
Please provide your email address to receive an email when new articles are posted on . Pivmecillinam was approved for uncomplicated urinary tract infections for women. Pivmecillinam led to higher ...
The FDA approved pivmecillinam (Pivya) for the treatment of uncomplicated urinary tract infections (UTIs) in women caused by Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus, the ...
April 24 (UPI) --The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract infections, the U.S. Food and Drug Administration announced ...
On Friday, Iterum Therapeutics plc (NASDAQ:ITRM) received FDA approval for its Orlynvah (sulopenem etzadroxil and probenecid) for uncomplicated urinary tract infections (uUTIs) caused by the ...
(RTTNews) - Iterum Therapeutics plc (ITRM) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Iterum's new drug application for Orlynvah (sulopenem etzadroxil and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback